Adult Vaccines Market, By Vaccine Type, By Technology, By Application, By Distribution Channel, By Geography

Description

Adult Vaccines Market is estimated to be valued at USD 32.8 Bn in 2026 and is expected to reach USD 51.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.69% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 32.8 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.69%	2033 Value Projection:	USD 51.6 Bn

The global adult vaccines market, being a significant segment of the preventive healthcare market, aims at offering immunization solution services to individuals aged 18 years and above. This market segment is vital in the prevention of vaccine-preventable diseases and the reduction of healthcare costs.

Adult vaccines are different in the sense that they offer immunization solution services to individuals based on the risk of acquiring diseases and immunity levels in adults. This market segment offers various immunization solution services, such as influenza, pneumococcal, hepatitis, HPV, meningococcal, and travel vaccines, among other newer vaccines such as shingles and RSV.

The market growth is driven by factors such as the rising awareness of preventive healthcare, the increasing incidence of chronic diseases which compromise immunity, and the widening recommendations for vaccinations by health authorities. The COVID-19 pandemic has also helped raise the awareness and acceptability of adult vaccination, which is further driving the market growth. In addition, the development of new vaccine technologies, including mRNA, is expected to improve the efficacy of vaccines, thereby driving the market growth.

Market Dynamics

The global adult vaccines market is influenced by a number of factors that create a favorable environment for growth. For instance, an aging population is more susceptible to infections like influenza, pneumococcal disease, and shingles. In addition, an increase in diabetes and heart conditions has made adults more susceptible to infections. Government initiatives aimed at cutting healthcare costs and preventive care are also a major influence. Vaccines are also being driven by an increase in international travel and health programs at the workplace. In addition, advances in vaccine technology are making vaccines more effective and accessible to adults.

However, some factors that inhibit growth in this market are vaccine hesitancy, high R&D costs, and regulatory hurdles. In addition, poor healthcare infrastructure in some parts of the world is a major hindrance to growth.

Despite these challenges, some of the opportunities that are available in this market are a growing healthcare infrastructure in emerging markets, a rise in disposable incomes, and an increase in preventive healthcare. For instance, combination vaccines and digital technologies are making vaccines more accessible and effective.

Key Features of the Study

This report provides in-depth analysis of the global adult vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global adult vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc, GlaxoSmithKline plc, Merck & Co Inc, Sanofi, Johnson and Johnson, Moderna, AstraZeneca plc, CSL Limited , Serum Institute of India, and Bharat Biotech
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult vaccines market

Market Segmentation

Vaccine Type Insights (Revenue, USD Bn, 2021 - 2033)
- Influenza
- Hepatitis
- Human Papillomavirus (HPV)
- Pneumococcal
- Tetanus Diphtheria and Pertussis
- COVID-19
- Others
Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Conjugate Vaccines
- Recombinant Vaccines
- mRNA Vaccines
- Toxoid Vaccines
Application Insights (Revenue, USD Bn, 2021 - 2033)
- Preventive
- Therapeutic
Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Clinics
- Retail Pharmacies
- Government and Public Health Programs
- Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc
- GlaxoSmithKline plc
- Merck & Co Inc
- Sanofi
- Johnson and Johnson
- Moderna
- AstraZeneca plc
- CSL Limited
- Serum Institute of India
- Bharat Biotech

Product Code: CMI1091

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Adult Vaccines Market, By Vaccine Type
- Global Adult Vaccines Market, By Technology
- Global Adult Vaccines Market, By Application
- Global Adult Vaccines Market, By Distribution Channel
- Global Adult Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trends

4. Global Adult Vaccines Market, By Vaccine Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Hepatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Human Papillomavirus (HPV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Pneumococcal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Tetanus Diphtheria and Pertussis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
COVID-19
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Adult Vaccines Market, By Technology, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Inactivated and Subunit Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
mRNA Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Adult Vaccines Market, By Application, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Preventive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Therapeutic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Adult Vaccines Market, By Distribution Channel, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Government and Public Health Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Adult Vaccines Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Moderna
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CSL Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Serum Institute of India
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us